293 related articles for article (PubMed ID: 1329991)
1. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV production in cells containing an integrated, HIV-regulated diphtheria toxin A chain gene.
Harrison GS; Long CJ; Maxwell F; Glode LM; Maxwell IH
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):39-45. PubMed ID: 1736939
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
[TBL] [Abstract][Full Text] [Related]
4. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
[TBL] [Abstract][Full Text] [Related]
5. Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene.
Curiel TJ; Cook DR; Wang Y; Hahn BH; Ghosh SK; Harrison GS
Hum Gene Ther; 1993 Dec; 4(6):741-7. PubMed ID: 8186289
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
7. Effects of enhancer mutations on the expression of human immunodeficiency virus 1-regulated luciferase and diphtheria toxin A chain genes in transfected cells.
Harrison GS; Long CJ; Castillo I
Toxicon; 1993 Jan; 31(1):85-90. PubMed ID: 8446966
[TBL] [Abstract][Full Text] [Related]
8. Cationic liposome-mediated expression of HIV-regulated luciferase and diphtheria toxin a genes in HeLa cells infected with or expressing HIV.
Konopka K; Harrison GS; Felgner PL; Düzgüneş N
Biochim Biophys Acta; 1997 Apr; 1356(2):185-97. PubMed ID: 9150276
[TBL] [Abstract][Full Text] [Related]
9. HIV-regulated diphtheria toxin A chain gene confers long-term protection against HIV type 1 infection in the human promonocytic cell line U937.
Dinges MM; Cook DR; King J; Curiel TJ; Zhang XQ; Harrison GS
Hum Gene Ther; 1995 Nov; 6(11):1437-45. PubMed ID: 8573616
[TBL] [Abstract][Full Text] [Related]
10. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
11. Helper plasmids for production of HIV-1-derived vectors.
Fuller M; Anson DS
Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
[TBL] [Abstract][Full Text] [Related]
12. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
14. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
15. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha stimulates HIV-1 production in primary culture of human adipocytes.
Maurin T; Saillan-Barreau C; Cousin B; Casteilla L; Doglio A; Pénicaud L
Exp Cell Res; 2005 Apr; 304(2):544-51. PubMed ID: 15748898
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
19. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
[TBL] [Abstract][Full Text] [Related]
20. Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.
Konopka K; Lee NS; Rossi J; Düzgüneş N
Gene; 2000 Sep; 255(2):235-44. PubMed ID: 11024283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
